Clinical Trial

A Study of the Effects of Itraconazole on LY4395089 in Healthy Participants

Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated June 16, 2026 (before its estimated July 2026 completion). Its status may not reflect the trial's current state.
Summary
The purpose of the study is to see how itraconazole affects LY4395089 in healthy participants. Blood tests will be performed to investigate how the body processes the study drug and how the study drug affects the body. There will be fifteen inpatient stays at the clinical research unit (CRU). The study will last about 2 weeks.
Protocol Amendment History 1 change
critical Recruitment opened 2026-06-17
Trial Details
NCT Number NCT07592572
Lead Sponsor Eli Lilly and Company
Conditions Healthy
Enrollment 14 participants
Start Date 2026-05-20
Primary Completion 2026-07 (estimated)
Study Completion 2026-07 (estimated)
Updated on ClinicalTrials.gov 2026-06-16